These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1643297)
1. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis. Dhillon J; Dickinson JM; Guy JA; Ng TK; Mitchison DA Tuber Lung Dis; 1992 Apr; 73(2):116-23. PubMed ID: 1643297 [TBL] [Abstract][Full Text] [Related]
2. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection. Shoen CM; DeStefano MS; Cynamon MH Clin Infect Dis; 2000 Jun; 30 Suppl 3():S288-90. PubMed ID: 10875802 [TBL] [Abstract][Full Text] [Related]
3. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages. Dhillon J; Mitchison DA Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967 [TBL] [Abstract][Full Text] [Related]
4. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348 [TBL] [Abstract][Full Text] [Related]
5. Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens. Daniel N; Lounis N; Ji B; O'Brien RJ; Vernon A; Geiter LJ; Szpytma M; Truffot-Pernot C; Hejblum G; Grosset J Am J Respir Crit Care Med; 2000 May; 161(5):1572-7. PubMed ID: 10806157 [TBL] [Abstract][Full Text] [Related]
6. Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Grosset J; Lounis N; Truffot-Pernot C; O'Brien RJ; Raviglione MC; Ji B Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1436-40. PubMed ID: 9603120 [TBL] [Abstract][Full Text] [Related]
7. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
8. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis. Park SW; Tasneen R; Converse PJ; Nuermberger EL Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368 [TBL] [Abstract][Full Text] [Related]
9. Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection. Zhang T; Zhang M; Rosenthal IM; Grosset JH; Nuermberger EL Am J Respir Crit Care Med; 2009 Dec; 180(11):1151-7. PubMed ID: 19729664 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice]. Nakanaga K; Saito H; Ishii N; Goto M Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873 [TBL] [Abstract][Full Text] [Related]
11. A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis. Veziris N; Ibrahim M; Lounis N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V Am J Respir Crit Care Med; 2009 Jan; 179(1):75-9. PubMed ID: 18948422 [TBL] [Abstract][Full Text] [Related]
12. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. Byrne ST; Denkin SM; Zhang Y J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Tam CM; Chan SL; Lam CW; Dickinson JM; Mitchison DA Int J Tuberc Lung Dis; 1997 Oct; 1(5):411-6. PubMed ID: 9441094 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice. Lenaerts AM; Chase SE; Chmielewski AJ; Cynamon MH Antimicrob Agents Chemother; 1999 Oct; 43(10):2356-60. PubMed ID: 10508006 [TBL] [Abstract][Full Text] [Related]
15. [Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages]. Saito H; Sato K; Tomioka H Kekkaku; 1988 Mar; 63(3):173-9. PubMed ID: 2836650 [No Abstract] [Full Text] [Related]
17. [Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice]. Grosset J; Truffot-Pernot C; Lecoeur H; Guelpa-Lauras CC Pathol Biol (Paris); 1983 May; 31(5):446-50. PubMed ID: 6353339 [TBL] [Abstract][Full Text] [Related]
18. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Chapuis L; Ji B; Truffot-Pernot C; O'Brien RJ; Raviglione MC; Grosset JH Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1355-62. PubMed ID: 7952564 [TBL] [Abstract][Full Text] [Related]
19. In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis. Dickinson JM; Mitchison DA Tubercle; 1987 Sep; 68(3):183-93. PubMed ID: 2834843 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]